Diabetic polyneuropathy. Axonal or demyelinating?

Electromyography and Clinical Neurophysiology

Volumn 42, Issue 1, 2002, Pages 3-6

  Valls Canals, J ^a   Povedano, M ^a   Montero, J ^a   Pradas, J ^a  

^a NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATING NEUROPATHY; DIABETIC NEUROPATHY; DISEASE CLASSIFICATION; ELECTROMYOGRAPHY; FEMALE; HUMAN; LEG MUSCLE; MALE; MUSCLE DENERVATION; MUSCLE REINNERVATION; NERVE CONDUCTION; NERVE FIBER DEGENERATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; PERONEUS NERVE; SURAL NERVE; SYMPTOM;

AGED; AGED, 80 AND OVER; AXONS; DEMYELINATING DISEASES; DIABETIC NEUROPATHIES; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL;

EID: 0036158721     PISSN: 0301150X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nerve biopsy and conduction studies in diabetic neuropathy
2. Diabetic neuropathy
3. Diabetic neuropathy: Pathophysiology and management
4. The glycosylation of hemoglobin: Relevance to diabetes mellitus
5. The pathogenesis of sural nerve chance in diabetes mellitus
6. Sensory nerve conduction in patients with diabetes and controls
7. Pathology
8. The Rochester Diabetic Neuropathy Study: Design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic test
9. Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy
10. Estudio de la velocidad de conducción nerviosa en la diabetes
11. Sorbitol pathway: Presence in nerve and cord with substrate accumulation in diabetes
12. Clinical value of motor nerve conduction velocity determination
13. Motor nerve conduction velocity in diabetes
14. Diabetic neuropathy; A clinical study of 150 cases
15. The neuropathies associated with diabetes mellitus
16. Diabetic neuropathy
17. Schwann-cell abnormalities in diabetic neuropathy
18. Effect of blood sugar control on the accumulation of sorbitol and fructose in nervous tissue
19. Protein modification by non-enzymatic glycosylation: Possible role in the development of diabetic complications